84 related articles for article (PubMed ID: 2359345)
1. Absence of bcr rearrangement and bcr/abl RNA in a patient with a 31-year survival of CML.
Sproul AM; Mills KI; McDonald GA; Burnett AK
Leukemia; 1990 Jun; 4(6):450-1. PubMed ID: 2359345
[No Abstract] [Full Text] [Related]
2. Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.
Selleri L; Emilia G; Temperani P; Grassilli E; Zucchini P; Tagliafico E; Bonati A; Venezia L; Ferrari S; Torelli U
Leukemia; 1989 Jul; 3(7):538-42. PubMed ID: 2733455
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis.
Price CM; Foadi MD; Morgan GJ; Wiedemann LM
Leukemia; 1990 Jun; 4(6):455-7. PubMed ID: 2359347
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
5. Remarkably long survival of a patient with Ph1-positive chronic myeloid leukemia and 5' bcr rearrangement.
Johansson B; Mertens F; Fioretos T; Heim S; Kristoffersson U; Mandahl N; Bartram CR; Mitelman F
Leukemia; 1990 Jun; 4(6):448-9. PubMed ID: 2359344
[TBL] [Abstract][Full Text] [Related]
6. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
7. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
8. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
9. Philadelphia chromosome-positive leukemia: molecular analysis of bcr and abl genes and transforming genes.
Okabe M; Matsushima S
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1471-80. PubMed ID: 3247820
[No Abstract] [Full Text] [Related]
10. M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.
Zaccaria A; Martinelli G; Buzzi M; Zuffa E; Zamagni MD; Testoni N; Russo D; Guerrasio A; Saglio G; Tura S
Haematologica; 1992; 77(1):16-20. PubMed ID: 1398276
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
13. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
14. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
16. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia.
Tassinari A; Zaccaria A; Saglio G; Guerrasio A; Testoni N; Celso B; Rosti G; Cambrin GR; Tura S
Haematologica; 1988; 73(4):326-7. PubMed ID: 3139538
[No Abstract] [Full Text] [Related]
18. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
19. Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement.
Min GL; Martiat P; Pu GA; Goldman J
Leukemia; 1990 Sep; 4(9):650-6. PubMed ID: 2395384
[TBL] [Abstract][Full Text] [Related]
20. Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia.
Romero P; Beran M; Shtalrid M; Andersson B; Talpaz M; Blick M
Oncogene; 1989 Jan; 4(1):93-8. PubMed ID: 2915904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
